A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...

Drug can be used to prevent catching the virus and treat those who have it Kampala, Uganda | THE INDEPENDENT & AGENCIES | A ...

According to the World Health Organization (WHO), lenacapavir offers a highly effective, long-acting alternative to daily ...

Scientists say the drug stops the virus from replicating inside cells. The landmark deal to provide cheaper antiretroviral ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir ...

Uganda is among the 10 high-burden countries selected to benefit through the US President’s Emergency Plan for Aids Relief ...

Press Release - The U.S. Department of State announced a life-saving development to bring U.S.-based Gilead Sciences' breakthrough drug lenacapavir to market in Uganda, one of just ten high-burden HIV ...

Cheap generic versions of a groundbreaking HIV-prevention jab should be available in more than 100 countries from 2027, ...

Two Indian generic drugmakers – Hetero and Dr Reddy’s – will be funded by the Gates Foundation and Unitaid, respectively, to ...

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...